ArticleClinical & experimental metastasis2003

EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma.

Ben Davidson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.